What Phantom Share Units did Randy Dobbs settle at Viemed Healthcare (VMD)?

Dobbs settled 4,191 Phantom Share Units granted under Viemed’s Phantom Share Unit Plan. Each phantom share is the economic equivalent of one common share, settled for cash and reported as acquisition and simultaneous disposition of underlying common shares.

Viemed Healthcare director gets 16.8K RSUs

Q: What insider equity award activity did VMD director Randy Dobbs report?

Randy Dobbs reported vesting and settlement of prior Restricted Stock Units and Phantom Share Units and a new grant of 16,848 RSUs, along with a 4,191-share disposition of common shares back to Viemed Healthcare for cash.

Q: How many Viemed Healthcare (VMD) Restricted Stock Units vested for Randy Dobbs?

On August 19, 2026, 16,763 Restricted Stock Units vested for Randy Dobbs, each RSU representing a contingent right to receive one common share, resulting in the acquisition of an equal number of Viemed Healthcare common shares.

Q: At what price were Randy Dobbs’ VMD common shares disposed to the issuer?

Dobbs disposed of 4,191 common shares to Viemed Healthcare at $8.94 per share, a value based on the market closing price of the company’s common shares on August 19, 2026, according to the filing footnote.

Q: What new RSU grant did Randy Dobbs receive from Viemed Healthcare (VMD)?

On August 17, 2026, Dobbs received a grant of 16,848 Restricted Stock Units. These RSUs were granted at a $0.00 price per unit and are scheduled to vest on the first anniversary of the grant date, August 17, 2027.

VIEMED HEALTHCARE, INC.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

VIEMED HEALTHCARE, INC. (VMD) director Randy E. Dobbs reported a series of equity award events. On August 19, 2026, previously granted 16,763 Restricted Stock Units and 4,191 Phantom Share Units vested and were settled, resulting in the acquisition of corresponding common shares and a simultaneous disposition of 4,191 common shares to the company for cash at $8.94 per share. The phantom units are cash-settled awards economically equivalent to common shares. On August 17, 2026, Dobbs also received a new grant of 16,848 Restricted Stock Units that vest on the first anniversary of the grant date.

Insider Trade Summary

20,954 shares exercised/converted

Exercise 6 txns

Insider Dobbs Randy E.

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units ^{F1, F4}	16,763	$0.00	$0.00
Exercise	Phantom Share Units ^{F2, F5}	4,191	$0.00	$0.00
Exercise	Common Shares ^F1	16,763	--	--
Exercise	Common Shares ^F2	4,191	--	--
Disposition	Common Shares ^F3	4,191	$8.94	$37K
Grant/Award	Restricted Stock Units ^{F1, F6}	16,848	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 16,848 contracts (Direct); Phantom Share Units — 0 contracts (Direct); Common Shares — 142,253 shares (Direct)

Footnotes (6)

F1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F2. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F3. Per share value is based on the market closing price of the common shares for August 19, 2026.
F4. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
F5. On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.
F6. Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.

Key Figures

RSUs vested into common shares: 16,763 shares Phantom Share Units settled: 4,191 units Disposition price to issuer: $8.94 per share +3 more

6 metrics

RSUs vested into common shares 16,763 shares Restricted Stock Units vested and converted into common shares on August 19, 2026

Phantom Share Units settled 4,191 units Cash-settled phantom shares vested and were settled on August 19, 2026

Disposition price to issuer $8.94 per share Common shares disposed to Viemed Healthcare at market closing price on August 19, 2026

Common shares disposed to issuer 4,191 shares Shares returned to Viemed Healthcare for cash on August 19, 2026

New RSU grant 16,848 units Restricted Stock Units granted on August 17, 2026, vesting on first anniversary

Derivative exercises 20,954 shares Total underlying shares in derivative exercises (code M) reported in this Form 4

Key Terms

Restricted Stock Units, Phantom Share Units, cash-settled phantom shares, economic equivalent

4 terms

Restricted Stock Units financial

"Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

cash-settled phantom shares financial

"Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan"

economic equivalent financial

"Each phantom share is the economic equivalent of one Company common share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity award activity did VMD director Randy Dobbs report?

Randy Dobbs reported vesting and settlement of prior Restricted Stock Units and Phantom Share Units and a new grant of 16,848 RSUs, along with a 4,191-share disposition of common shares back to Viemed Healthcare for cash.

How many Viemed Healthcare (VMD) Restricted Stock Units vested for Randy Dobbs?

On August 19, 2026, 16,763 Restricted Stock Units vested for Randy Dobbs, each RSU representing a contingent right to receive one common share, resulting in the acquisition of an equal number of Viemed Healthcare common shares.

At what price were Randy Dobbs’ VMD common shares disposed to the issuer?

Dobbs disposed of 4,191 common shares to Viemed Healthcare at $8.94 per share, a value based on the market closing price of the company’s common shares on August 19, 2026, according to the filing footnote.

What new RSU grant did Randy Dobbs receive from Viemed Healthcare (VMD)?

On August 17, 2026, Dobbs received a grant of 16,848 Restricted Stock Units. These RSUs were granted at a $0.00 price per unit and are scheduled to vest on the first anniversary of the grant date, August 17, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/19/2026 - 04:31 PM Accepted by SEC EDGAR 08/19/2026 - 04:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dobbs Randy E.

(Last)

(First)

(Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE

LOUISIANA

70508

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	08/19/2026		M		16,763	A	⁽¹⁾	142,253	D
Common Shares	08/19/2026		M		4,191	A	⁽²⁾	146,444	D
Common Shares	08/19/2026		D		4,191	D	$8.94⁽³⁾	142,253	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	08/19/2026		M			16,763	⁽⁴⁾	⁽⁴⁾	Common Shares	16,763	$0	0	D
Phantom Share Units	⁽²⁾	08/19/2026		M			4,191	⁽⁵⁾	⁽⁵⁾	Common Shares	4,191	$0	0	D
Restricted Stock Units	⁽¹⁾	08/17/2026		A		16,848		⁽⁶⁾	08/17/2027	Common Shares	16,848	$0	16,848	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

3. Per share value is based on the market closing price of the common shares for August 19, 2026.

4. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.

5. On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.

6. Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR